The rapid evolution of the CRISPR-Cas9 gene editing field has led to a proliferation of technology formats and applications that can seem intimidating for the first-time researcher.
Lentiviral particles can be an essential delivery tool for difficult-to-transfect cells. However, regulations regarding biosafety features can sometimes make the technology intimidating for a first-time user.